SNWV SANUWAVE Health, Inc.

OTC sanuwave.com


$ 31.07 $ 4.67 (17.68 %)    

Friday, 07-Nov-2025 15:59:59 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 31.08
$ 30.00
$ 25.00 x 25
$ 31.98 x 1
$ 28.04 - $ 31.71
$ 24.80 - $ 46.59
219,829
na
284.09M
$ -2,567.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-20-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-26-2022 03-31-2022 10-Q
16 05-13-2022 12-31-2021 10-K
17 02-28-2022 09-30-2021 10-Q
18 01-14-2022 06-30-2021 10-Q
19 12-13-2021 03-31-2021 10-Q
20 10-21-2021 12-31-2020 10-K
21 11-23-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-20-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-19-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-29-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-08-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.32 by...

Core News & Articles

Reimbursement for the 97610 code for UltraMIST products remains materially unchanged for 2026 with payment for treatment provid...

 stock-market-today-dow-jones-nasdaq-100-sp-500-futures-turn-greentrilogy-metals-amd-applovin-in-focus-updated

Editor’s Note: The future prices of benchmark tracking ETFs and lede were updated in the story.) US futures trimmed earlier ...

 mccormick-telomir-pharmaceuticals-and-3-stocks-to-watch-heading-into-tuesday

U.S. stock futures mixed, key stocks to watch: MKC, SNWV, PENG, TELO, SAR. Check out premarket coverage. Cramer warns on chip s...

Core News & Articles

Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating a...

Core News & Articles

Roth Capital analyst Kyle Bauser maintains SANUWAVE Health (NASDAQ:SNWV) with a Buy and raises the price target from $54 to ...

Core News & Articles

Financial OutlookThe Company forecasts Q3 2025 revenue of $12-$12.7 million and reiterates full year 2025 revenue guidance of $...

Core News & Articles

SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.09) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION